Sangui Biotech International Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Thomas Striepe
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 16.2yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$43k |
| Dec 31 2023 | n/a | n/a | -US$100k |
| Sep 30 2023 | n/a | n/a | -US$163k |
| Jun 30 2023 | n/a | n/a | -US$148k |
| Mar 31 2023 | n/a | n/a | -US$125k |
| Dec 31 2022 | n/a | n/a | -US$101k |
| Sep 30 2022 | n/a | n/a | -US$9k |
| Jun 30 2022 | US$83k | US$83k | -US$59k |
| Mar 31 2022 | n/a | n/a | -US$102k |
| Dec 31 2021 | n/a | n/a | -US$87k |
| Sep 30 2021 | n/a | n/a | -US$151k |
| Jun 30 2021 | US$80k | US$80k | -US$199k |
| Mar 31 2021 | n/a | n/a | -US$218k |
| Dec 31 2020 | n/a | n/a | -US$245k |
| Sep 30 2020 | n/a | n/a | -US$225k |
| Jun 30 2020 | US$75k | US$75k | -US$193k |
| Mar 31 2020 | n/a | n/a | -US$234k |
| Dec 31 2019 | n/a | n/a | -US$274k |
| Sep 30 2019 | n/a | n/a | -US$276k |
| Jun 30 2019 | US$68k | US$68k | -US$324k |
| Mar 31 2019 | n/a | n/a | -US$230k |
| Dec 31 2018 | n/a | n/a | -US$235k |
| Sep 30 2018 | n/a | n/a | -US$231k |
| Jun 30 2018 | US$19k | US$19k | -US$202k |
Compensation vs Market: Insufficient data to establish whether Thomas's total compensation is reasonable compared to companies of similar size in the German market.
Compensation vs Earnings: Thomas's compensation has increased whilst the company is unprofitable.
CEO
Thomas Striepe (62 yo)
16.2yrs
Tenure
US$82,621
Compensation
Mr. Thomas Striepe has been the Chief Executive Officer of Sangui Biotech International, Inc. since April 8, 2008 and serves as its Chief Financial Officer. Mr. Striepe serves as the Vice President of Acco...